(JULY 28, 2022) Sean Diehl, Ph.D., associate professor of microbiology and molecular genetics, spoke with CT Insider about an Omicron-specific mRNA vaccine developed by Yale scientists that creates a strong antibody response against subvariants BA.1 and BA.2.12.1.
Sean Diehl, Ph.D.
(JULY 28, 2022) Sean Diehl, Ph.D., associate professor of microbiology and molecular genetics, spoke with CT Insider about an Omicron-specific mRNA vaccine developed by Yale scientists that creates a strong antibody response against subvariants BA.1 and BA.2.12.1. “The Yale study is an interesting proof-of-concept study,” he said. “They made this all themselves and that’s a really good thing for the democratization of these vaccines.”
Read full story
at
CT Insider